Institutional shares held 61.1 Million
17.6K calls
1.11M puts
Total value of holdings $123M
$35K calls
$2.22M puts
Market Cap $97.8M
48,656,800 Shares Out.
Institutional ownership 125.54%
# of Institutions 119


Latest Institutional Activity in NKTX

Top Purchases

Q1 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 17.4K ($34.9K)
Q1 2025
Pallas Capital Advisors LLC Shares Held: 13.1K ($26.4K)
Q1 2025
Founders Capital Management Shares Held: 5K ($10K)
Q1 2025
Amalgamated Bank Shares Held: 1.83K ($3.67K)
Q1 2025
Uma Financial Services, Inc. Shares Held: 667 ($1.34K)

Top Sells

Q1 2025
Rhumbline Advisers Shares Held: 78.2K ($157K)
Q1 2025
Sg Americas Securities, LLC Shares Held: 23.7K ($47.7K)
Q1 2025
Mirae Asset Global Investments Co., Ltd. Shares Held: 2.33K ($4.68K)
Q4 2024
Commodore Capital LP Shares Held: 352K ($707K)
Q4 2024
Orbimed Advisors LLC Shares Held: 821K ($1.65M)

About NKTX

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.


Insider Transactions at NKTX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
396K Shares
From 6 Insiders
Grant, award, or other acquisition 396K shares
Sell / Disposition
57.3K Shares
From 7 Insiders
Open market or private sale 55.9K shares
Grant, award, or other acquisition 1.35K shares

Track Institutional and Insider Activities on NKTX

Follow Nkarta, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTX shares.

Notify only if
Any

Insider Trading

Get notified when an Nkarta, Inc. insider buys or sells NKTX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Nkarta, Inc.

Track Activities on NKTX